On August 3rd, 2023, GlaxoSmithKline Consumer Nigeria Plc (GLAXOSMITH) released a circular disclosing its decision to cease operations in Nigeria. The document outlined GSK UK Group’s plan to discontinue sales of prescription medicines and vaccines in Nigeria through the GSK local operating companies. In its stead, it intends to introduce a direct distribution model involving a local third-party, distributing GSK pharmaceutical product in the Nigerian market. It’s worth noting that GSK Group holds 46.42% of GlaxoSmithKline Consumer Nigeria Plc through Setfirst Limited (27.31%) and Smithkline Beecham Limited (19.11%), while the remaining 53.58% is owned by the investing public.
You May Also Like
Daily Market Report for 7th July 2022
- July 8, 2022
Kindly click the link below to access our stock market report for today, 7th July 2022 Daily Stock…
Equity Note – TRANSCORP Shares Reconstruction
- May 15, 2024
Dear All, Kindly find attached the report. Regards, Equity Note – TRANSCORP Shares Reconstruction
Exploring Short-Term Market Opportunity
- June 19, 2023
Kindly find attached. Exploring Short-Term Market Opportunity
FIDELITYBK Rights Issue Note
- July 1, 2024
Dear All, Kindly find attached the report. Regards, FIDELITYBK Rights Issue Note
Consumer Goods Sector Update (Shifting Landscape for Consumer Goods Players)
- January 5, 2024
Dear All, Kindly find attached the report. Regards. Consumer Goods Sector Update (Shifting Landscape for Consumer Goods Players)
Banking Sector Update – Taxing Times, Windfall Worries
- July 30, 2024
Dear All, Kindly find attached the report. Regards, Banking Sector Update – Taxing Times, Windfall Worries